approval
saveLEQVIO (INCLISIRAN SODIUM) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 7
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalFeb 12, 2026 · 235d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalJul 31, 2025 · 431d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalJun 6, 2024 · 851d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalJul 7, 2023 · 1186d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalFeb 17, 2023 · 1326d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalJun 6, 2022 · 1582d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalDec 22, 2021 · 1748d ago
same company · ±60 days · 6
- approvalinclisiran: LEQVIO (INCLISIRAN SODIUM) — FDA approvalFeb 12, 2026
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalMar 12, 2026
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalMar 12, 2026
comments(0)
5-min edit window · permanent after that